Lululemon's core problem is identified not as competition, but as a failure in product execution and innovation, particularly in its core North American women's business. The company has brought in new leadership with a product background, but the long pipeline means a significant turnaround is not anticipated until mid-2027.
The $75 billion SpaceX IPO is a major market event, having been quickly oversubscribed. The discussion covers the intense investor demand, the potential for significant retail investor participation, and the possibility that investors are selling other tech holdings to raise capital for this offering.
Broadcom's earnings report showcases the explosive growth in AI-related revenue, with sales up 143% and guidance for over 200% growth. This strength suggests the AI infrastructure spending cycle remains in its early stages, with key suppliers like Broadcom executing well against their strategic pivot to AI.
An outbreak of a dangerous Ebola strain is spreading in a conflict zone, a situation made worse by a crisis in the global health system. Drastic funding cuts by the US (83% cut in aid) and other G7 nations, coupled with the US withdrawal from the WHO, have dismantled surveillance and response networks.
The S&P 500 has decided against fast-tracking newly public companies for index inclusion and will maintain its 12-month profitability requirement. This decision has significant implications for major, high-growth but currently unprofitable tech companies like SpaceX, Anthropic, and OpenAI, potentially delaying their inclusion for years.
Keep pulling the thread on Bloomberg Intelligence.